CXCR3 and papilloma: At 6 weeks post-infection, we quantified infiltrating CD4+ and CD8+ T cells in the remaining papillomas that did not completely regress in K17KO control mice, papillomas in K17KO mice blocked with anti-CXCR3 and papillomas in untreated WT mice.